SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
BioCardia, Inc.
@BCDA_InsiderForm 4 Filing: Altman Peter Buys $5,208.3 of $BCDA
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
BioCardia, Inc.
Ticker: $BCDA
Transaction Value
$5,208.3
Price/Share: $0.96
transaction date
2026-07-08
Shares: 5,400
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Altman Peter, holds the title of President and CEO at BioCardia, Inc..
On 2026-07-08, the insider transacted 5,400 shares.The shares were transacted at a weighted average price of $0.96 per share, resulting in a total market-relevant value of $5,208.3.
Executive Summary Summary
Altman Peter (President and CEO) bought $5K of $BCDA
Post-Transaction Position: 361,985 shares
SEC Accession No: 0001437749-26-023016 (CIK: 1647542)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.